Patrizia Giannatempo, Matthew D. Galsky, Ignacio Duran, Valentina Boni, Andrea Necchi, Antoine Italiano, Meredith McKean, Loic Verlingue, Rama Balaraman, Leslie Robbins DeMars, Kate Josephs, Cong Xu, Oscar Reig Torras. "Phase 1/2 Duravelo-1 study: Preliminary results of nectin-4–targeting zelenectide pevedotin (BT8009) plus pembrolizumab in previously untreated, cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4567